INNOMOL

Enhancement of the Innovation Potential in SEE through new Molecular Solutions in Research and Development

Coordinatore	RUDER BOSKOVIC INSTITUTE    more  Organization address address: Bijenicka cesta 54 city: ZAGREB postcode: 10000 contact info Titolo: Dr. Nome: Oliver Cognome: Vugrek Email: send email Telefono: 38514560946 Fax: 38514561010
Nazionalità Coordinatore	Croatia [HR]
Totale costo	5˙313˙649 €
EC contributo	4˙738˙978 €
Programma	FP7-REGPOT Specific Programme "Capacities": Research potential of Convergence Regions
Code Call	FP7-REGPOT-2012-2013-1
Funding Scheme	CSA-SA
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-06-01   -   2016-11-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	RUDER BOSKOVIC INSTITUTE  Organization address address: Bijenicka cesta 54 city: ZAGREB postcode: 10000 contact info Titolo: Dr. Nome: Oliver Cognome: Vugrek Email: send email Telefono: 38514560946 Fax: 38514561010	HR (ZAGREB)	coordinator	4˙738˙978.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'The InnoMol project will foster a research pipeline at the Rudjer Boskovic Institute (RBI) and facilitate new avenues of innovation and technology for the investigation of relevant diseases. As InnoMol goals are oriented to the future development of possible diagnostic, preventive and/or therapeutic approaches for the major diseases of the world, it is essential to have access to a center of excellence that can provide the cross-functional and project-oriented alignment of resources and expertises along the value chain leading towards an innovative product. The project will bring together and reinforce 3 major worlds of life sciences, e.g. Medicine, Biology, and Chemistry to create a productive, state-of-the-art environment that is unique in the region and will bridge the gap between the pre-commercial and commercial phases of R&D, thus enhancing the relevance of the RBI’s position in the European Research Area (ERA). The fully assembled research pipeline will enable inter- and, multidisciplinary research in the field of Molecular Biosciences with focus on DNA-Protein, Protein-Protein, Protein-RNA, DNA-RNA and DNA-DNA interactions. The tangible outcomes of the Action will be innovative molecular solutions for investigating major global diseases in order to transfer the knowledge to the community for the generation of wealth and public wellbeing.'